J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 7,640.00
+120.00 (1.60%)
At close: Apr 3, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 44.67 billion as of April 2, 2026. Its market cap has decreased by -37.90% in one year.
Market Cap
44.67B
Enterprise Value
33.11B
Revenue
32.97B
Ranking
n/a
PE Ratio
16.64
Stock Price
7,640.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 44.67B, a decrease of -69.17%. That is a compound annual growth rate of -44.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 44.67B | -11.16% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 62.68B |
| SunBio,Inc. | 61.70B |
| IMGT Co.,Ltd. | 59.71B |
| Parataxis Korea | 49.64B |
| ADBiotech | 49.49B |
| NGeneBio | 43.38B |
| MOA Life Plus | 40.65B |
| Kainos Medicine | 35.56B |